Related Experiment Video
Updated: Aug 9, 2026

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
Published on: September 27, 2024
Diadenosines as FHIT-ness instructors
Manuela Campiglio1, Francesca Bianchi, Francesca Andriani
1Department of Experimental Oncology, Molecular Biology Unit, Istituto Nazionale Tumori, Milan, Italy. manuela.campiglio@istitutotumori.mi.it
The FHIT gene, a tumor suppressor, is often inactivated in human cancers. Its precise oncosuppressive mechanisms and interactions, beyond its known hydrolase activity, are still being explored in cancer research.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- The Fragile Histidine Triad (FHIT) gene functions as a tumor suppressor, frequently inactivated in various human cancers.
- While Fhit protein's diadenosine triphosphate (Ap3A) hydrolase activity is established, it's not essential for its tumor-suppressive role.
- The molecular pathways and regulatory elements governing FHIT's oncosuppression remain largely unelucidated.
Purpose of the Study:
- To review the physiological and pathological roles of FHIT in relation to Ap(n)A signaling molecules.
- To explore the involvement of FHIT in apoptosis and cell cycle regulation within cancer models.
- To discuss novel FHIT interactions that may reveal new hypotheses on its biochemical oncosuppressor mechanisms.
Main Methods:
- Literature review of existing studies on FHIT.
- Analysis of FHIT's role in Ap(n)A signaling pathways.
- Examination of FHIT's involvement in apoptosis and cell cycle control.
- Discussion of recent findings on FHIT protein interactions.
Main Results:
- FHIT's tumor suppressor function is independent of its Ap3A hydrolase activity.
- FHIT is implicated in regulating apoptosis and cell cycle progression in cancer.
- Emerging evidence points to novel protein interactions influencing FHIT's oncosuppressive activity.
Conclusions:
- The precise biochemical mechanisms of FHIT's tumor suppressor activity are complex and not fully understood.
- Further research into FHIT's interactions and its role in signaling pathways is crucial for understanding its oncosuppressive function.
- FHIT remains a significant target for cancer research due to its established role as a tumor suppressor gene.
More Related Videos
05:58A Novel Nicotinamide Adenine Dinucleotide Correction Method for Intracellular Ca2+ Measurement with Fura-2-Analog in Live Cells
Published on: September 20, 2019
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
FISH - Fluorescent In-situ Hybridization
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...